Multi-Channel Gastric Electrical Stimulation for the Treatment of Gastroparesis
NCT ID: NCT00595621
Last Updated: 2019-05-31
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
22 participants
INTERVENTIONAL
2006-02-28
2009-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Gastric Pacemaker Implantation for Gastroparesis
NCT00568373
Escalating Temporary Gastric Electrical Stimulation (GES) for Severe Gastroparesis
NCT02164591
Temporary Gastric Electrical Stimulation for Drug Refractory Gastroparesis
NCT00432835
Temporary Gastric Electrical Stimulation for Gastroparesis
NCT01054794
Study of Enhanced Programming Stimulation with the Enterra® Therapy System
NCT06560307
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MGP-1 ON
Experimental Pacemaker on for 6 weeks
Enterra Multi-Channel Phased Gastric Pacemaker (MGP-1)
Multi-Channel Phased Gastric Pacemaker (MGP-1)
MGP-1 OFF
Experimental Pacemaker on or off for 4 weeks
Enterra Multi-Channel Phased Gastric Pacemaker (MGP-1)
Multi-Channel Phased Gastric Pacemaker (MGP-1)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Enterra Multi-Channel Phased Gastric Pacemaker (MGP-1)
Multi-Channel Phased Gastric Pacemaker (MGP-1)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Documented delayed gastric emptying
* Failed extensive medical treatment
Exclusion Criteria
* Pregnancy or planned pregnancy
* Primary eating or swallowing disorders
* Scheduled or planned MRI testing
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
GI Stimulation, Inc.
INDUSTRY
National Institutes of Health (NIH)
NIH
American Diabetes Association
OTHER
University of Kansas Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Richard W. McCallum, MD
Role: PRINCIPAL_INVESTIGATOR
University of Kansas Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Kansas Medical Center
Kansas City, Kansas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
9459
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.